The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Shiga Toxin--Producing Escherichia coli Infection
Abstract
Large-scale outbreaks of Shiga toxin-producing Escherichia coli (STEC) infection have revealed the great disease-causing potential of this organism, especially among children and elderly persons. Approximately 5%-10% of people with STEC infection will develop hemolytic-uremic syndrome (HUS), approximately 10% of those who develop HUS will die or have permanent renal failure, and up to 50% of those who develop HUS will develop some degree of renal impairment. Important concepts in understanding the pathogenesis and prevention of STEC-associated HUS are emerging, although no specific therapy yet exists. Optimal management of STEC infection includes intravenous hydration, avoidance of antimotility agents and antimicrobials, and monitoring for sequelae. Antimicrobials may have a potentially harmful role, possibly by inducing intestinal production of Shiga toxin during the diarrheal phase of illness. A recent clinical trial evaluating an intraluminal Shiga toxin-binding agent to ameliorate HUS showed no improvement in outcome. Interventions to prevent HUS from developing in STEC-infected children are under investigation. Prevention of exposure to STEC remains important, and animal vaccines to prevent stool shedding of STEC among food animals are in development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Escherichia coli O157: H7 Diarrhea in the United States: Clinical and Epidemiologic Features
Slutsker, L., Ries, A. A., Greene, K. D., Wells, J. G., Hutwagner, L., & Griffin, P. M. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-7-199704010-00002 · Cited by 282
Cited by
Noris, M., & Remuzzi, G. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004100861 · Cited by 635
The role of microbiota in infectious disease
Stecher, B., & Hardt, W.-D. (2008) · Trends in Microbiology · doi:10.1016/j.tim.2007.12.008 · Cited by 535
Escherichia coli Pathobionts Associated with Inflammatory Bowel Disease
Mirsepasi-Lauridsen, H. C., Vallance, B. A., Krogfelt, K. A., & Petersen, A. M. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00060-18 · Cited by 359
Carbohydrate-Based Macromolecular Biomaterials
Su, L., Feng, Y., Wei, K., Xu, X., Liu, R., & Chen, G. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01338 · Cited by 335
The Human/Animal Interface: Emergence and Resurgence of Zoonotic Infectious Diseases
Greger, M. (2007) · Critical Reviews in Microbiology · doi:10.1080/10408410701647594 · Cited by 304
Metadata
- Authors
- Thorpe, C. M.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-05-01
- Volume
- 38
- Issue
- 9
- Pages
- 1298-1303
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2161908003
- Cited by
- 190
- References
- 1
- FWCI
- 8.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Shiga Toxin--Producing Escherichia coli Infection. https://app.cochat.ai/papers/10.1086/383473
- The paper
- Thorpe, C. M. (2004). Shiga Toxin--Producing Escherichia coli Infection. Clinical Infectious Diseases. https://doi.org/10.1086/383473
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.